XNAS · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Idexx Laboratories (IDXX) had 1 Form 144 pre-sale notice filed on 2026-05-20. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 6/1/2026 | FENNELL GEORGE | Executive Vice President | OPTION_EXERCISE | -639 | — | — |
| 6/1/2026 | FENNELL GEORGE | Executive Vice President | TAX_WITHHOLD | -284 | $567 | $160,968 |
| 6/1/2026 | FENNELL GEORGE | Executive Vice President | OPTION_EXERCISE | 639 | — | — |
| 5/12/2026 | Britt Irene Chang | — | GRANT | 234 | — | — |
| 5/12/2026 | Britt Irene Chang | — | GRANT | 525 | — | — |
| 5/12/2026 | Claflin Bruce L. | — | GRANT | 234 | — | — |
| 5/12/2026 | Claflin Bruce L. | — | GRANT | 525 | — | — |
| 5/12/2026 | ESSIG STUART | — | GRANT | 234 | — | — |
| 5/12/2026 | ESSIG STUART | — | GRANT | 525 | — | — |
| 5/12/2026 | HOOLEY JOSEPH L | — | GRANT | 234 | — | — |
| 5/12/2026 | HOOLEY JOSEPH L | — | GRANT | 525 | — | — |
| 5/12/2026 | JUNIUS DANIEL M | — | GRANT | 234 | — | — |
| 5/12/2026 | JUNIUS DANIEL M | — | GRANT | 525 | — | — |
| 5/12/2026 | Kingsley Lawrence D | — | GRANT | 75 | — | — |
| 5/12/2026 | Kingsley Lawrence D | — | GRANT | 234 | — | — |
| 5/12/2026 | Kingsley Lawrence D | — | GRANT | 168 | — | — |
| 5/12/2026 | Kingsley Lawrence D | — | GRANT | 525 | — | — |
| 5/12/2026 | Peacock Karen | — | GRANT | 234 | — | — |
| 5/12/2026 | Peacock Karen | — | GRANT | 525 | — | — |
| 5/12/2026 | SAMAD SAM | — | GRANT | 234 | — | — |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| 5/20/2026 | Margaret Anne Szostak | — | — | SEC |